Sort
48,018 grants matching “immunotherapy”
Big data and small molecules for Alzheimer's disease
$801,219Weiming Xia · Boston University Medical Campus · R01 · FY2025 · AG
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
$801,160Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2021 · AI
Regulation And Function Of Retroelements
$801,152Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Targeting the Epigenome for Lung Cancer Therapy
$800,874David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Protective Human Monoclonal Antibodies to HIV-1
$800,505Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2010 · HL
Mechanisms of CTL Resistance in HIV Reservoirs
$800,474R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
Protective Human Monoclonal Antibodies to HIV-1
$800,269Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2012 · HL
Regulatory T cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$800,066Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI
Hijacking the T cell machinery for logic-gated CAR T cell control
$800,041Robbie G. Majzner · Stanford University · DP2 · FY2021 · CA
UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT
$800,002University Of Puerto Rico Med Sciences · U01 · FY2002 · AI
Nanomedicine development center for mechanobiology
$800,000Michael L Dustin · New York University School Of Medicine · PN2 · FY2013 · EY
SOUTHWEST ONCOLOGY GROUP--OPERATIONS OFFICER
$800,000Cancer Therapy And Research Center · U10 · FY2000 · CA
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$800,000Stephen J Galli · Stanford University · U19 · FY2024 · AI
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$799,908David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HL
Protective Human Monoclonal Antibodies to HIV-1
$799,591Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2014 · HL
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
$799,560Alexander B Sigalov · Signablok, Inc. · R44 · FY2019 · CA
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$799,422Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2014 · CA
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$799,089Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2020 · HL
Generation of highly differentiated NK cells to synergize with broadly neutralizing antibodies to establish viral control in absence of ART
$799,017Mirko Paiardini · Emory University · R01 · FY2024 · AI
Role of mouse microbiome in cancer and inflammation
$798,983Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Regulation of human dendritic cell activation
$798,983Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Determinants of oral anaphylaxis to food
$798,975Adam Williams · Northwestern University At Chicago · R01 · FY2024 · AI
Immunotherapy for Malignant Mesothelioma
$798,901Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Clinical Trials Engine Lentiviral engineered T cells for HIV
$798,675Carl H. June · University Of Pennsylvania · U19 · FY2008 · AI
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$798,543Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · R35 · FY2019 · CA